This inventor holds 4 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Agency for Science, Technology and Research, Singapore Health Services Pte Ltd. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011-2015
Title: Lei Zhou: Innovator in Antimicrobial Peptides
Introduction
Lei Zhou is a prominent inventor based in Singapore, known for his contributions to the field of antimicrobial peptides. With a total of 4 patents, Zhou has made significant strides in developing innovative solutions to combat microbial growth.
Latest Patents
One of Zhou's latest patents focuses on multimeric forms of antimicrobial peptides, particularly defensin peptides. This invention highlights the antimicrobial activity of these multimeric forms, which can be formulated into various compositions, including pharmaceutical and eyedrop solutions. The invention also addresses the use of these peptides to inhibit and reduce the growth of microorganisms, making it a valuable asset in medical applications. Furthermore, Zhou has developed a method for preparing multimers of peptides derived from defensins, such as hBD3, which includes a combination of the multimeric antimicrobial peptides and at least one active pharmaceutical ingredient.
Career Highlights
Throughout his career, Lei Zhou has worked with notable organizations, including Singapore Health Services Pte Ltd and the Agency for Science, Technology and Research. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Zhou has collaborated with esteemed colleagues, including Roger Wilmer Beuerman and Shouping Liu, who have played a role in his research endeavors.
Conclusion
In summary, Lei Zhou is a distinguished inventor whose work on antimicrobial peptides has the potential to revolutionize medical treatments. His innovative approaches and collaborations continue to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile